Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. (BLCM) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · BLCM · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Bellicum Pharmaceuticals, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
BLCM insider buying and selling by quarter
BLCM insider selling · BLCM insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
BLCM executive sell shares · BLCM board member insider trading · BLCM insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 22, 2023 | BAKER BROS. ADVISORS LP 10 percent owner | Other | 1,941,607 | $194 | Form 4 |
| Nov 22, 2023 | BAKER BROS. ADVISORS LP 10 percent owner | Other | 174,742 | $17 | Form 4 |
| Jan 3, 2023 | Daly James M Director | Option | 60,414 | — | Form 4 |
| Jan 3, 2023 | DAVIS STEPHEN Director | Option | 74,739 | — | Form 4 |
| Jan 3, 2023 | Huber Reid M Director | Option | 87,196 | — | Form 4 |
| Jan 3, 2023 | Stonehouse Jon P Director | Option | 121,452 | — | Form 4 |
| Jan 3, 2023 | Klimovsky Judith V Director | Option | 60,414 | — | Form 4 |
| Sep 1, 2022 | Klimovsky Judith V Director | Option | 35,082 | — | Form 4 |
| Sep 1, 2022 | DAVIS STEPHEN Director | Option | 43,400 | — | Form 4 |
| Sep 1, 2022 | Daly James M Director | Option | 35,082 | — | Form 4 |
| Sep 1, 2022 | Huber Reid M Director | Option | 46,489 | — | Form 4 |
| Sep 1, 2022 | Stonehouse Jon P Director | Option | 60,580 | — | Form 4 |
| Jan 4, 2022 | Huber Reid M Director | Option | 19,494 | — | Form 4 |
| Jan 4, 2022 | BROWN JAMES F Director | Option | 28,384 | — | Form 4 |
| Jan 4, 2022 | Stonehouse Jon P Director | Option | 21,504 | — | Form 4 |
| Jan 4, 2022 | Daly James M Director | Option | 809 | — | Form 4 |
| Jan 4, 2022 | Daly James M Director | Option | 13,568 | — | Form 4 |
| Jan 4, 2022 | Klimovsky Judith V Director | Option | 566 | — | Form 4 |
| Jan 4, 2022 | Klimovsky Judith V Director | Option | 14,036 | — | Form 4 |
| Jan 4, 2022 | DAVIS STEPHEN Director | Option | 18,715 | — | Form 4 |
| May 29, 2020 | Ward Shane Sr VP and Chief Legal SO | Other | 107 | $816 | Form 4 |
| Mar 17, 2020 | Fair Richard A. President and CEO · Director | Purchase | 5,000 | $20K | Form 4 |
| Jan 3, 2020 | Williams Rosemary Y. VP, Finance & PAO | Option | 781 | — | Form 4 |
BAKER BROS. ADVISORS LP
10 percent owner
Date
Nov 22
Shares
1,941,607
Price
$0.00
Value
$194
BAKER BROS. ADVISORS LP
10 percent owner
Date
Nov 22
Shares
174,742
Price
$0.00
Value
$17
Fair Richard A.
President and CEO · Director
Date
Mar 17
Shares
5,000
Price
$4.00
Value
$20K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About BLCM insider trading
BLCM insider trades
Bellicum Pharmaceuticals, Inc. (BLCM) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including BLCM. Over the past 12 months, 0 insiders have filed transactions with the SEC. BLCM insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Bellicum Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
BLCM insider trading · 5 questionsThe insiders of Bellicum Pharmaceuticals, Inc. (BLCM) include executives and directors such as BLCM, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026